Table 1.

Circulating levels of angiopoietin-1, angiopoietin-2, Tie2, vWF, and endoglin in patients who were survivors and nonsurvivors of COVID-19

BiomarkersStatusDerivation cohortValidation cohort
MeanStandard deviationPMeanStandard deviationP
Angiopoietin-1, pg/mL Nonsurvivor 20.083 7.168 .882 16.518 12.243 .914 
Survivor 19.148 11.520 17.078 12.243 
Angiopoietin-2, pg/mL Nonsurvivor 2.765 2.455 .246 1.808 0.879 .424 
Survivor 2.125 1.855 2.156 1.628 
Angiopoietin-2/angiopoietin-1 Nonsurvivor 0.383 0.210 .007 0.298 0.260 .040 
Survivor 0.084 0.015 0.159 0.128 
Tie2, pg/mL Nonsurvivor 18.608 7.830 .883 19.803 8.987 .766 
Survivor 19.772 9.169 20.518 7.732 
vWF, ng/mL Nonsurvivor 283.7 17.5 .395 NA NA NA 
Survivor 266.4 40.1 NA NA NA 
Endoglin, pg/mL Nonsurvivor 2.535 689 .660 2.533 788 .293 
Survivor 1.937 447 2.284 783 
BiomarkersStatusDerivation cohortValidation cohort
MeanStandard deviationPMeanStandard deviationP
Angiopoietin-1, pg/mL Nonsurvivor 20.083 7.168 .882 16.518 12.243 .914 
Survivor 19.148 11.520 17.078 12.243 
Angiopoietin-2, pg/mL Nonsurvivor 2.765 2.455 .246 1.808 0.879 .424 
Survivor 2.125 1.855 2.156 1.628 
Angiopoietin-2/angiopoietin-1 Nonsurvivor 0.383 0.210 .007 0.298 0.260 .040 
Survivor 0.084 0.015 0.159 0.128 
Tie2, pg/mL Nonsurvivor 18.608 7.830 .883 19.803 8.987 .766 
Survivor 19.772 9.169 20.518 7.732 
vWF, ng/mL Nonsurvivor 283.7 17.5 .395 NA NA NA 
Survivor 266.4 40.1 NA NA NA 
Endoglin, pg/mL Nonsurvivor 2.535 689 .660 2.533 788 .293 
Survivor 1.937 447 2.284 783 

NA, not available.

or Create an Account

Close Modal
Close Modal